US BANCORP \DE\ - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$964
-82.9%
88
-79.4%
0.00%
Q2 2023$5,653
+60.4%
427
+64.9%
0.00%
Q1 2023$3,525
-83.2%
259
-74.5%
0.00%
Q2 2022$21,000
+162.5%
1,017
+295.7%
0.00%
Q1 2022$8,000
+60.0%
257
+123.5%
0.00%
Q4 2021$5,000
+66.7%
1150.0%0.00%
Q3 2021$3,0001150.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders